---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-23-000357"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:17:11.540436+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Globus Medical enters $400M credit facility, authorizes $350M stock buyback

## Summary
- $400M unsecured credit agreement with U.S. Bank as agent; matures Sept 2028.
- New $350M stock repurchase program approved by board with no time limit.
- About $150.8M remains from prior repurchase programs announced in 2020 and 2022.
- Credit facility includes $200M accordion feature, SOFR-based pricing (margin 1.125%-1.625%).
- Loan parties include NuVasive as guarantor; leverage ratio covenant applies.

## SEC filing metadata
- accession: 0001562762-23-000357
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000357/0001562762-23-000357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000357/gmed-20230927x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-23-000357
- JSON: https://secwatch.observer/filing/0001562762-23-000357.json
- Plain text: https://secwatch.observer/filing/0001562762-23-000357.txt

## Key facts
- Material Agreements
  GLOBUS MEDICAL INC entered into Credit Agreement with U.S. Bank National Association, as the administrative agent valued at $400 million (effective 2023-09-27).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: U.S. Bank National Association, as the administrative agent
  - Value: $400 million
  - Effective: 2023-09-27
  source text: On September 27, 2023, Globus Medical, Inc. (the “Company”), together with Globus Medical North America, Inc., the Company’s wholly-owned subsidiary (with the Company, the “Borrowers”) entered into an unsecured credit agreement (the “Credit Agreement”) with U.S. Bank National Association, as the administrative agent (the “Agent”), Citizens Bank, N.A., as syndication agent, Royal Bank of Canada, as the documentation agent, U.S. Bank National Association and Citizens Bank, N.A., as joint lead arrangers and joint book runners, and the other lenders referred to therein.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000357/0001562762-23-000357-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.